A team of researchers at IDIBAPS-Hospital Clínic Barcelona has shown that the Greenhabit mobile application can be useful for controlling Type 2 diab1
A team from Clínic-IDIBAPS led a collaborative study that characterized in detail the genetic profile of testicular B-cell lymphoma, a very rare lymp1
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. Inv1
A team from Clínic-IDIBAPS has introduced a modification to a CAR-T immunotherapy for multiple myeloma that makes it more durable, according to resul1
Conducted as part of the MELCAYA project, the study demonstrates that anti PD-1 antibody immunotherapy is safe for children and adolescents. Furtherm1
Workers from IDIBAPS and other Campus Clínic organisations are eligible to take part. Each worker may submit a maximum of 3 photographs.
A team from the Clínic-IDIBAPS, the Institute of Neurosciences UBNeuro and the University of Barcelona led by Yaroslau Compta has participated in an1
Performing antitachycardia pacing (ATP) before a direct current shock to stop cardiac arrhythmias through an implanted defibrillator has certain limi1
Last week, IDIBAPS hosted the annual scientific meeting of the European Inter-Group for Childhood Non-Hodgkin Lymphoma (EICNHL). The event brought to1
